Life-Sciences-France.com
The French Life Sciences Web Portal

This is a free web portal for the life sciences in France and Monaco... » read more

genOway Grants UK Research Funder CRISPR/Cas9 License (2022-01-25)
This agreement will help pharmaceutical and biotech industries to get safe access to leading expertise and preclinical models from UK academic institutions genOway (Euronext Growth® Paris - ISIN: FR0004053510 - ALGEN), which specializes in the development of i...
77 Foods (La Vie) Raises €25m Series A for Plant-based Meat (2022-01-19)
> The first record raising of €25M in Series A financing from investment funds led by Seventure, and international celebrities that are committed to protecting the planet. This includes Natalie Portman (actress, director, producer) and the CEOs of Vinted, Blablacar...
Inova, Backed by Carlyle, Acquires Labiotech.eu (2022-01-18)
Inova, the leading biopharma partnering platform, has acquired Labiotech, an independent news media covering European biotech innovation. This acquisition follows a €60 million investment from global investment firm Carlyle (NASDAQ: CG) in 2021 and reaffirms the st...
Exscientia & Sanofi: up to $5.3b Research Collaboration (2022-01-07)
> Collaborative efforts aim to accelerate drug discovery and improve clinical success > Agreement to utilize Exscientia’s AI-based capabilities and personalised medicine platform from target identification through patient selection > Research will be focused ...
DNA Script Closes $200m Series C Financing with 2nd Tranche (2022-01-04)
> Accounts and funds advised by T. Rowe Price Associates, Inc. and Baillie Gifford join syndicate of investors > Funding to accelerate commercial launch of revolutionary enzymatic DNA printing technology DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS...
Onxeo Appoints Board Director Julien Miara as Interim CEO (2022-01-03)
Onxeo S.A. (Euronext Growth Paris: ALONX, First North Copenhagen: ONXEO), (“Onxeo” or “the Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage response (DDR), today announced the appointme...
Noxxon: €17m Expansion of Equity-linked Facility with Atlas (2022-01-03)
> Substantial extension of financial runway visibility into December 2022 > Financing availability secured for initiation of NOX-A12 Phase 2/3 in Glioblastoma and Phase 2 in Pancreatic Cancer, both on track to start in Q3 2022 This press release corrects a pri...
Antigon Raises €1.5m to CE Mark Portable Blood Typing Device (2021-12-22)
New corporate investors join Sambrinvest & BeAngels in enlarged round Antigon SA, which is developing ISABO, a portable device for ultimate safety and traceability of blood transfusions via double verification, has raised €1.5m to help it finalize development ...
Sanofi to Acquire Amunix for $1b Upfront & $224m Milestones (2021-12-21)
> Adds promising pipeline of T-cell engagers and cytokine therapies with lead candidate AMX-818 expected to enter the clinic in early 2022 > Provides access to Amunix Pro-XTENTM, XPAT®, and XPACTM technology, complementary to Sanofi’s existing R&D platforms ...
Ipsen Licenses Elafibranor from Genfit with $120m Upfront (2021-12-17)
> Agreement gives Ipsen global* rights to develop and commercialize GENFIT’s late-stage, first-in-class PPAR alpha and delta agonist elafibranor in Primary Biliary Cholangitis (PBC) > Investigational treatment elafibranor being evaluated in the global Phase III ...

Life-Sciences-France.com is your doorway to the French life sciences!

[LSF] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in France and Monaco.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSF] is 100% Made in Germany!

» Start here with the latest News!

Picture Kentro Design Is Key to Your Success Berlin 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

» top